Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole for Hyperprolactinemia
NCT03038308Phase 2Completed
- Sponsor
- Columbia University
- Start
- Sep 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole in hyperprolactinemia, prolactinoma, sponsored by Columbia University. Started Sep 2016; status: completed.
02
Drugs
ropinirole
03
Conditions
hyperprolactinemiaprolactinoma
Beyond the preview
Go deeper on NCT03038308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038308.